{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:04:58Z","timestamp":1793387098440,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,6,26]],"date-time":"2019-06-26T00:00:00Z","timestamp":1561507200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,6,26]],"date-time":"2019-06-26T00:00:00Z","timestamp":1561507200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Leverhulme Mandela Rhodes Scholarship","award":["None"],"award-info":[{"award-number":["None"]}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["110110"],"award-info":[{"award-number":["110110"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Medical Research Council UK, Oxford NIHR Biomedical Research Centre","award":["None"],"award-info":[{"award-number":["None"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12889-019-7095-4","type":"journal-article","created":{"date-parts":[[2019,6,26]],"date-time":"2019-06-26T10:02:33Z","timestamp":1561543353000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Modelling cost-effectiveness of tenofovir for prevention of mother to child transmission of hepatitis B virus (HBV) infection in South Africa"],"prefix":"10.1186","volume":"19","author":[{"given":"Jolynne","family":"Mokaya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward A. O.","family":"Burn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia Raissa","family":"Tamandjou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Goedhals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor J.","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Pinedo-Villanueva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4036-4269","authenticated-orcid":false,"given":"Philippa C.","family":"Matthews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,26]]},"reference":[{"key":"7095_CR1","unstructured":"WHO. Combating hepatitis B and C to reach elimination by 2030. Advocacy Brief. 2016. http:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/206453\/WHO_HIV_2016.04_eng.pdf;jsessionid=34488ABA33BD359C8415A10205FBEC09?sequence=1 ."},{"key":"7095_CR2","unstructured":"WHO. Hepatitis B Fact sheet 2018. Available from: http:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-b ."},{"issue":"6","key":"7095_CR3","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S2468-1253(18)30056-6","volume":"3","author":"D Razavi-Shearer","year":"2018","unstructured":"Razavi-Shearer D, et al. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. Lancet Gastroenterol Hepatol. 2018;3(6):383\u2013403.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"10159","key":"7095_CR4","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1016\/S0140-6736(18)32203-7","volume":"392","author":"GBD 2017 Causes of Death Collaborators","year":"2018","unstructured":"GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1736\u201388.","journal-title":"Lancet"},{"issue":"2","key":"7095_CR5","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1046\/j.1365-2893.2003.00487.x","volume":"11","author":"D. Lavanchy","year":"2004","unstructured":"Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. Viral Hepat. 2004;11(2):97\u2013107.","journal-title":"Journal of Viral Hepatitis"},{"key":"7095_CR6","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jcv.2016.02.003","volume":"77","author":"P Yi","year":"2016","unstructured":"Yi P, Chen R, Huang Y, Zhou R-R, Fan X-G. Management of mother-to-child transmission of hepatitis B virus: propositions and challenges. J Clin Virol. 2016;77:32\u20139.","journal-title":"J Clin Virol"},{"issue":"3","key":"7095_CR7","doi-asserted-by":"publisher","first-page":"241","DOI":"10.14218\/JCTH.2016.00014","volume":"4","author":"WS Ayoub","year":"2016","unstructured":"Ayoub WS, Cohen E. Hepatitis B Management in the Pregnant Patient: an update. J Clin Transl Hepatol. 2016;4(3):241\u20137.","journal-title":"J Clin Transl Hepatol"},{"key":"7095_CR8","doi-asserted-by":"crossref","unstructured":"Lampertico P, et al. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol. 2017;67(2):370\u201398. https:\/\/easl.eu\/publication\/management-of-hepatitis-b-virus-infection\/ .","DOI":"10.1016\/j.jhep.2017.03.021"},{"issue":"Suppl 1","key":"7095_CR9","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1093\/jpids\/piu064","volume":"3 Suppl 1","author":"NP Nelson","year":"2014","unstructured":"Nelson NP, Jamieson DJ, Murphy TV. Prevention of perinatal Hepatitis B virus transmission. J Pediatric Infect Dis Soc. 2014;3 Suppl 1(Suppl 1):S7\u201312.","journal-title":"J Pediatric Infect Dis Soc"},{"key":"7095_CR10","unstructured":"McNaughton A, et al. Can we meet global challenges for elimination of Hepatitis B virus infection by 2030? Vaccine-mediated immunity in a south African cohort and a model of transmission and prevention. Preprint at https:\/\/www.biorxiv.org\/content\/early\/2017\/11\/09\/162594 (2017)."},{"key":"7095_CR11","unstructured":"WHO. Immunization, Vaccines and Biologicals: Hepatitis B. https:\/\/www.who.int\/immunization\/diseases\/hepatitisB\/en\/ (2018)."},{"key":"7095_CR12","unstructured":"WHO | guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection. 2015. http:\/\/www.who.int\/hiv\/pub\/hepatitis\/hepatitis-b-guidelines\/en\/ ."},{"issue":"3 Part B","key":"7095_CR13","doi-asserted-by":"publisher","first-page":"463","DOI":"10.3851\/IMP1555","volume":"15","author":"M-H Chang","year":"2010","unstructured":"Chang M-H. Breakthrough HBV infection in vaccinated children in Taiwan: surveillance for HBV mutants. Antivir Ther. 2010;15(3 Part B):463\u20139.","journal-title":"Antivir Ther"},{"issue":"24","key":"7095_CR14","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1056\/NEJMoa1508660","volume":"374","author":"CQ Pan","year":"2016","unstructured":"Pan CQ, et al. Tenofovir to prevent Hepatitis B transmission in mothers with high viral load. N Engl J Med. 2016;374(24):2324\u201334.","journal-title":"N Engl J Med"},{"issue":"12","key":"7095_CR15","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1111\/apt.14068","volume":"45","author":"MH Hyun","year":"2017","unstructured":"Hyun MH, et al. Systematic review with meta-analysis: the efficacy and safety of tenofovir to prevent mother-to-child transmission of hepatitis B virus. Aliment Pharmacol Ther. 2017;45(12):1493\u2013505.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"7095_CR16","doi-asserted-by":"publisher","first-page":"4132","DOI":"10.1038\/s41598-017-04479-x","volume":"7","author":"J-Z Chen","year":"2017","unstructured":"Chen J-Z, et al. Efficacy and safety of tenofovir disoproxil fumarate in preventing vertical transmission of hepatitis B in pregnancies with high viral load. Sci Rep. 2017;7(1):4132.","journal-title":"Sci Rep"},{"issue":"4","key":"7095_CR17","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1002\/hep.29800","volume":"67","author":"Norah A. Terrault","year":"2018","unstructured":"Terrault NA, et al. Update on Prevention, Diagnosis, and Treatment of Chronic Hepatitis B: AASLD 2018 Hepatitis B Guidance. Hepatology. 2018;67(4):1560\u201399.","journal-title":"Hepatology"},{"issue":"42","key":"7095_CR18","doi-asserted-by":"publisher","first-page":"11941","DOI":"10.3748\/wjg.v21.i42.11941","volume":"21","author":"R Zampino","year":"2015","unstructured":"Zampino R, et al. Hepatitis B virus burden in developing countries. World J Gastroenterol. 2015;21(42):11941\u201353.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"7095_CR19","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jcv.2014.05.018","volume":"61","author":"PC Matthews","year":"2014","unstructured":"Matthews PC, Geretti AM, Goulder PJR, Klenerman P. Epidemiology and impact of HIV coinfection with hepatitis B and hepatitis C viruses in sub-Saharan Africa. J Clin Virol. 2014;61(1):20\u201333.","journal-title":"J Clin Virol"},{"issue":"7","key":"7095_CR20","doi-asserted-by":"publisher","first-page":"e358","DOI":"10.1016\/S2214-109X(15)00056-X","volume":"3","author":"MI Andersson","year":"2015","unstructured":"Andersson MI, et al. Mother-to-child transmission of hepatitis B virus in sub-Saharan Africa: time to act. Lancet Glob Heal. 2015;3(7):e358\u20139.","journal-title":"Lancet Glob Heal"},{"issue":"7","key":"7095_CR21","doi-asserted-by":"publisher","first-page":"e0181267","DOI":"10.1371\/journal.pone.0181267","volume":"12","author":"N Chotun","year":"2017","unstructured":"Chotun N, et al. Point-of-care screening for hepatitis B virus infection in pregnant women at an antenatal clinic: a South African experience. PLoS One. 2017;12(7):e0181267.","journal-title":"PLoS One"},{"issue":"10","key":"7095_CR22","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1111\/apt.13795","volume":"44","author":"E Keane","year":"2016","unstructured":"Keane E, Funk AL, Shimakawa Y. Systematic review with meta-analysis: the risk of mother-to-child transmission of hepatitis B virus infection in sub-Saharan Africa. Aliment Pharmacol Ther. 2016;44(10):1005\u201317.","journal-title":"Aliment Pharmacol Ther"},{"issue":"8","key":"7095_CR23","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1093\/infdis\/jiy028","volume":"217","author":"P Wilson","year":"2018","unstructured":"Wilson P, Parr JB, Jhaveri R, Meshnick SR. Call to action: prevention of mother-to-child transmission of Hepatitis B in Africa. J Infect Dis. 2018;217(8):1180\u20133.","journal-title":"J Infect Dis"},{"issue":"4","key":"7095_CR24","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1128\/JCM.02980-14","volume":"53","author":"HF Njai","year":"2015","unstructured":"Njai HF, et al. Validation of rapid point-of-care (POC) tests for detection of Hepatitis B surface antigen in field and laboratory settings in the Gambia, Western Africa. J Clin Microbiol. 2015;53(4):1156\u201363.","journal-title":"J Clin Microbiol"},{"issue":"4","key":"7095_CR25","doi-asserted-by":"publisher","first-page":"e111","DOI":"10.1097\/QAI.0b013e31825aeee7","volume":"60","author":"MI Andersson","year":"2012","unstructured":"Andersson MI, Maponga TG, Ijaz S, Theron G, Preiser W, Tedder RS. High HBV viral loads in HIV-infected pregnant women at a tertiary hospital, South Africa. JAIDS J Acquir Immune Defic Syndr. 2012;60(4):e111\u20132.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"issue":"1","key":"7095_CR26","doi-asserted-by":"publisher","DOI":"10.7448\/IAS.17.1.18871","volume":"17","author":"CJ Hoffmann","year":"2014","unstructured":"Hoffmann CJ, et al. Maternal hepatitis B and infant infection among pregnant women living with HIV in South Africa. J Int AIDS Soc. 2014;17(1):18871.","journal-title":"J Int AIDS Soc"},{"issue":"47","key":"7095_CR27","doi-asserted-by":"publisher","first-page":"5579","DOI":"10.1016\/j.vaccine.2013.08.028","volume":"31","author":"MI Andersson","year":"2013","unstructured":"Andersson MI, et al. The epidemiology of hepatitis B virus infection in HIV-infected and HIV-uninfected pregnant women in the Western cape, South Africa. Vaccine. 2013;31(47):5579\u201384.","journal-title":"Vaccine."},{"issue":"16","key":"7095_CR28","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1097\/QAD.0b013e328359590f","volume":"26","author":"JB Nachega","year":"2012","unstructured":"Nachega JB, et al. Adherence to antiretroviral therapy during and after pregnancy in low-income, middle-income, and high-income countries: a systematic review and meta-analysis. AIDS. 2012;26(16):2039\u201352.","journal-title":"AIDS"},{"key":"7095_CR29","unstructured":"South Africa National Health Laboratory Service (NHLS) and Department of Health price list. (2015)."},{"key":"7095_CR30","unstructured":"International Medical Products Price Guide. http:\/\/mshpriceguide.org (2015)"},{"key":"7095_CR31","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1007\/978-3-319-47266-9_26","volume-title":"Antimicrobial Drug Resistance","author":"Apostolos Beloukas","year":"2017","unstructured":"Beloukas A, Geretti AM. Hepatitis B virus drug resistance. In: Antimicrobial Drug Resistance. Cham: Springer International Publishing; 2017. p. 1227\u201342."},{"issue":"D1","key":"7095_CR32","doi-asserted-by":"publisher","first-page":"D566","DOI":"10.1093\/nar\/gks1022","volume":"41","author":"J. Hayer","year":"2012","unstructured":"Hayer J, et al. HBVdb: a knowledge database for Hepatitis B Virus. Nucleic Acids Res. 2013;41:D566\u2013D570. https:\/\/hbvdb.ibcp.fr\/HBVdb\/ (accessed on 18th April 2018).","journal-title":"Nucleic Acids Research"},{"issue":"2","key":"7095_CR33","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.jhep.2017.03.027","volume":"67","author":"Elham Shirvani-Dastgerdi","year":"2017","unstructured":"Shirvani-Dastgerdi E, et al. Selection of the highly replicative and partially multidrug resistant rtS78T HBV polymerase mutation during TDF-ETV combination therapy. J Hepatol. 2017;67(2):246\u201354.","journal-title":"Journal of Hepatology"},{"issue":"10","key":"7095_CR34","doi-asserted-by":"publisher","first-page":"e0005842","DOI":"10.1371\/journal.pntd.0005842","volume":"11","author":"Geraldine A. O\u2019Hara","year":"2017","unstructured":"O\u2019Hara GA, et al. Hepatitis B virus infection as a neglected tropical disease. PLoS Negl Trop Dis. 2017;11(10):e0005842.","journal-title":"PLOS Neglected Tropical Diseases"},{"key":"7095_CR35","doi-asserted-by":"publisher","first-page":"e1709","DOI":"10.7717\/peerj.1709","volume":"4","author":"W Wang","year":"2016","unstructured":"Wang W, Wang J, Dang S, Zhuang G. Cost-effectiveness of antiviral therapy during late pregnancy to prevent perinatal transmission of hepatitis B virus. PeerJ. 2016;4:e1709.","journal-title":"PeerJ."},{"issue":"5","key":"7095_CR36","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1002\/hep.28310","volume":"63","author":"Lin Fan","year":"2015","unstructured":"Fan L, Owusu-Edusei K, Schillie SF, Murphy TV. Cost-effectiveness of active-passive prophylaxis and antiviral prophylaxis during pregnancy to prevent perinatal hepatitis B virus infection. Hepatology. 2016;63(5):1471\u201380.","journal-title":"Hepatology"},{"key":"7095_CR37","doi-asserted-by":"crossref","unstructured":"Jourdain G, et al. Tenofovir versus placebo to prevent perinatal transmission of Hepatitis B. N Engl J Med. 2018;378(10):911\u201323.","DOI":"10.1056\/NEJMoa1708131"},{"issue":"8","key":"7095_CR38","doi-asserted-by":"publisher","first-page":"e0006629","DOI":"10.1371\/journal.pntd.0006629","volume":"12","author":"Jolynne Mokaya","year":"2018","unstructured":"Mokaya J, et al. A systematic review of hepatitis B virus (HBV) drug and vaccine escape mutations in Africa: a call for urgent action. PLoS Negl Trop Dis. 2018;12(8):e0006629.","journal-title":"PLOS Neglected Tropical Diseases"},{"key":"7095_CR39","unstructured":"Easterbrook P, et al. HIV and Hepatitis Testing: Global Progress, Challenges, and Future Directions. AIDS Rev. 2016;18(1):3-14.40."},{"issue":"12","key":"7095_CR40","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/S2468-1253(17)30295-9","volume":"2","author":"C Wendy Spearman","year":"2017","unstructured":"Spearman CW, et al. Hepatitis B in sub-Saharan Africa: strategies to achieve the 2030 elimination targets. Lancet Gastroenterol Hepatol. 2017;(12):900\u20139.","journal-title":"The Lancet Gastroenterology & Hepatology"},{"key":"7095_CR41","doi-asserted-by":"crossref","unstructured":"McNaughton A, et al. HBV vaccination and PMTCT as elimination tools in the presence of HIV: insights from a clinical cohort and dynamic model.BMC Med. 2019;17(1):43.","DOI":"10.1186\/s12916-019-1269-x"},{"key":"7095_CR42","unstructured":"WHO. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: Recommendations for a public health approach - Second edition. 2016. https:\/\/www.who.int\/hiv\/pub\/arv\/arv-2016\/en\/ . ISBN: 978 92 4 154968 4"},{"key":"7095_CR43","doi-asserted-by":"crossref","unstructured":"Lemoine M, & Thursz MR. Battlefield against hepatitis B infection and HCC in Africa. Journal of Hepatology. 2017;66:645\u2013654.","DOI":"10.1016\/j.jhep.2016.10.013"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-019-7095-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12889-019-7095-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-019-7095-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T20:24:05Z","timestamp":1663791845000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-019-7095-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,26]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["7095"],"URL":"https:\/\/doi.org\/10.1186\/s12889-019-7095-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/483966","asserted-by":"object"}]},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,26]]},"assertion":[{"value":"19 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"829"}}